Skip to main content
. 2020 Feb 12;59(9):1179–1187. doi: 10.2169/internalmedicine.4048-19

Table.

Laboratory Test Findings.

before the treatment before starting the third treatment before the treatment before starting the third treatment before the treatment before starting the third treatment
White Blood Cells 52.7×102/μL 58×102/μL TP 7.1 g/dL 7.7 g/dL cryoglobulins - ND
Neu 47.8% 48.6% Alb 4.2 g/dL 4.3g/dL free light chain κ/λ ND 0.75
Ly 35.9% 38.1% BUN 12.7 mg/dL 14.3 mg/dL M protein - -
Mon 5.5% 5.7% Cr 0.83 mg/dL 1.57mg/dL* ANA speckled pattern 1:40* -
Eo 10.2%* 6.4% eGFR 57.2 mL/min/1.73m2* 27.3mL/min/1.73m2* ANA cytoplasmic pattern 1:40* 1:40*
Ba 0.6% 1.2% UA 1.5 mg/dL* 1.8mg/dL* SS-A Ab ≤7.0U/mL ND
Red Blood Cells 417×104/μL 357×104/μL AST 25 IU/L 15 IU/L SS-B Ab ≤7.0U/mL ND
Hb 12.8 g/dL 11.4 g/dL* ALT 33 IU/L 11 IU/L antimitochondrial M2 Ab ND 141U/mL*
Ht 40.2% 36.5% ALP 725 IU/L* 673 IU/L* TSH 0.824μIU/mL 0.736μIU/mL
platelet 22.1×104/μL 23.3×104/μL ALP-2 34% ALP-1 3% free T4 0.97ng/dL 1.01ng/dL
PT-INR 0.88 0.95 ALP-3 66% ALP-2+3 97%
APTT 25.5 sec 27.0 sec T-Bil 0.8mg/dL 0.7mg/dL Urinalysis
γGTP 25 IU/L 13 IU/L pH 7.5* 8.5*
arterial blood gas (at rest) LDH 168 IU/L 182 IU/L Protein 1.4 g/ gCr* 2.6 g/gCr*
pH 7.323 ND T-Cho 200mg/dL ND alb 29.3% ND
PCO2 39.0 mmHg ND LDL-C 95mg/dL 90mg/dL α1-glb 11.0% ND
PO2 69.9 mmHg* ND Na 140mEq/L 141mEq/L α2-glb 23.2% ND
HCO3- 19.6 mEq/L* ND K 3.7mEq/L 3.3mEq/L* β2-glb 22.4% ND
A-aDO2 31.4 mmHg* ND CL 111mEq/L* 108mEq/L γ-glb 14.1% ND
SpO2 94.50% ND Ca 8.7mg/dL 9.8mg/dL Sugar 2+* 4+*
P 2.3mg/dL* 1.6mg/dL* 696mg/dL*
HBs Ag 0.00 IU/mL 0.00 IU/mL CRP 0.01mg/dL 0.02mg/dL Red Blood Cells 1.3 /HPF 1.2 /HPF
HCV Ab -II 0.07 S/CO 0.05 S/CO GLU 95mg/dL 93mg/dL White Blood Cells 2.9/HPF 2.4/HPF
HBs Ab ND 0.1 mIU/mL HbA1c (NGSP) 5.0% 5.4% Granular casts +* -
HBc Ab ND 0.05 S/CO Magnesium 2.6mg/dL 2.7mg/dL* Epithelial cell casts +* -
HIV Ab ND 0.1 S/CO Aluminum ≤10μg/L ND generalized aminoaciduria ND +*
PTH-intact 24.3pg/mL 52.0pg/mL NAG 9.0 U/L* 8.0 U/L*
interferon-gamma release assays - - 1, 25 (OH)2VD3 ND 26.8pg/mL β2MG 14,774μg/L* 64,978μg/L*
sputum culture no particular findings ND IgG 1,022mg/dL 837mg/dL* Bence Jones protein - ND
IgA 262mg/dL 261mg/dL Na 57mEq/L 56mEq/L
IgM 630mg/dL* 637mg/dL* K 21mEq/L 63.2mEq/L
IgG4 14.0mg/dL ND CL 44mEq/L 31mEq/L
C3 75mg/dL* 88.3mg/dL* urine Ca/Cr ratio ND 0.21*
C4 18mg/dL 20.9mg/dL
FEHCO3- ND 8.0%*
(after loading bicarbonate)
FEP ND 56.6%*
%TRP ND 43.4%*
TmP/GFR ND 0.95mg/dL*
FEUA 34.1%* 75.6%*
FEK 12%* 105.1%*

Asterisks (*) indicate abnormal values.

A-aDO2: alveolar-arterial oxygen difference, Ab: antibody, Ag: antigen, Alb: albumin, ALP: alkaline phosphatase, ALT: alanine aminotransferase, ANA: antinuclear antibody, APTT: activated partial thromboplastin time, AST: aspartate aminotransferase, Ba: basophils, β2MG: beta-2 microglobulin, BUN: blood urea nitrogen, Cr: creatinine, CRP: C-reactive protein, eGFR, estimated glomerular filtration rate, Eo: eosinophils, FECHO3-: fractional excretion of bicarbonate, FEK: fractional excretion of potassium, FEP: fractional excretion of phosphate, FEUA: fractional excretion of uric acid, glb: globulin, GLU: casual blood glucose, γGTP: gamma-glutamyl transpeptidase, Hb: hemoglobin, HBc: hepatitis B core, HBs: hepatitis B surface, HCV: hepatitis C virus, HIV: human immunodeficiency virus, Ht: hematocrit, Ig: immunoglobulin, LDH: lactate dehydrogenase, LDL-C: low-density lipoprotein cholesterol, Ly: lymphocytes, Mon: monocytes, NAG: N-acetyl-beta-D-glucosaminidase, ND: no data, Neu: neutrophils, NGSP: National Glycohemoglobin Standardization Program, PTH: parathyroid hormone, PT-INR: prothrombin time-international normalized ratio, SpO2: saturation of percutaneous oxygen, T-Cho: total cholesterol, T-Bil: total-bilirubin, TP: total protein, TRP: tubular re-absorption of phosphate, TSH: thyroid-stimulating hormone, TmP/GFR: tubular maximum of phosphate, T4: thyroxine 4, UA: uric acid, 1, 25 (OH)2VD3: 1, 25- dihydroxy vitamin D3